| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 58-49-1 | 血管紧张素 | Angiotensin acetate; Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asp-5-Val-angiotensin II; 1-L-Asparticacid-5-valine-angiotensin II; 1-a-L-Aspartic acid-5-L-valine-angiotensin II; 11: PN: US20090227507 SEQID:20 unclaimed Protein; 11: PN: US6762167 SEQID: 19 unclaimed sequence; 16: PN:WO0144270 SEQID: 19 claimed Protein; 178: PN: WO2008004992 SEQID: 42 unclaimedsequence; 17: PN: US20080293634 SEQID: 24 unclaimed sequence; 17: PN: WO0143761SEQID: 19 claimed Protein; 17: PN: WO0155176 SEQID: 19 claimed Protein; 17: PN:WO02087504 SEQID: 19 claimed Protein; 18: PN: WO0002905 SEQID: 19 claimedProtein; 18: PN: WO0198325 SEQID: 19 claimed Protein; 19: PN: US20030130196SEQID: 19 claimed Protein; 19: PN: WO0056345 SEQID: 19 claimed sequence; 23:PN: WO0069900 SEQID: 672 unclaimed sequence; 23: PN: WO9958140 SEQID: 19 claimedsequence; 24: PN: WO0069900 SEQID: 673 unclaimed sequence; 4: PN: WO0187976PAGE: 16 unclaimed sequence; 5-L-Valine angiotensin II; 5-Valine-angiotensinII; Angiotensin II(Alligator mississippiensis); Angiotensin II (ox); Angiotensin II 5-valine; L-Aspartyl-L-Arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-Prolyl-L-phenylAlanine; L-PhenylAlanine, N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl-]-L-histidyl]-L-Prolyl]-; Valine angiotensin II; [Val5] Angiotensin II, human; |  | C49H70N14O11 | 详情 | 供应商 |
| 159768-75-9 | Lobradimil | Lobradimil; Bradykinin,3-(trans-4-hydroxy-L-Proline)-5-[3-(2-thienyl)-L-Alanine]-8-de-L-phenylAlanine-9-[N2-[2-amino-3-(4-methoxyphenyl)Propyl]-L-Arginine]-,(S)-; 60: PN: WO03065997 SEQID: 90 unclaimed Protein; A 7; A 7 (peptide); Cereport; Labradimil; Lobradimil; RMP 7 |  | C49H75N15O12S | 详情 | 供应商 |
| 53-73-6 | 增血压素 | Angiotensin II,1-L-asparagine-5-L-valine-; Alanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asn2-5-Val-angiotensin II; 1-Asparagine-5-valineangiotensin II; 1-Asparaginyl-5-valyl-angiotensin II; 1-Aspartic acid-5-valine angiotensin IIamide; 1-Aspartic acid-b-amide 5-valine angiotensin II; 1-L-Asn-5-L-Val-angiotensin II; 1-L-Asparagine-5-L-valineangiotensin II; 1-L-Asparagine-5-L-valine-angiotensin; 1-L-Asparaginyl-5-L-valyl angiotensin octapeptide; 1-a-Asparagine-5-valine-angiotensinII; 12: PN: US20090227507 SEQID: 21 unclaimed Protein; 12: PN: US6762167 SEQID:20 unclaimed sequence; 17: PN: WO0144270 SEQID: 20 claimed Protein; 18: PN:WO0143761 SEQID: 20 claimed Protein; 18: PN: WO0155176 SEQID: 20 claimedProtein; 18: PN: WO02087504 SEQID: 20 claimed Protein; 19: PN: WO0002905 SEQID:20 claimed Protein; 19: PN: WO0198325 SEQID: 20 claimed Protein; 20: PN:US20030130196 SEQID: 20 claimed Protein; 20: PN: WO0056345 SEQID: 20 claimedsequence; 24: PN: WO9958140 SEQID: 20 claimed Protein; 5-L-Valine-angiotensinII amide; 5-Valine angiotensin II amide; 5-Valine angiotensin II aspartic-b-amide; 5-Valine angiotensinamide II; 5-Valine-angiotensin II-b-amide; 5-Valyl angiotensin II amide; 545: PN: US20090175821 SEQID: 655claimed Protein; 6: PN: WO0069900 SEQID: 655 unclaimed sequence; Angiotensin(Ciba); Angiotensin II (Oncorhynchus mykiss); Angiotensin II (eel); AngiotensinII amide; Angiotensin II amide 5-valine; Angiotensin II amide, 5-L-valine-; Angiotensin II aspartic-b-amide, 5-L-valine; Angiotensin II-5-valine-amide; Angiotensin amide; Angiotensin amide, 5-L-valine-; Hypertensin; Hypertensinamide; Hypertensine; Ipertensina; L-PhenylAlanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-; NSC 107678; Rainbow trout angiotensin II; Val-Hypertensin-II-asp-b-amide; Val5-angiotensin II amide |  | C49H70N14O11 | 详情 | 供应商 |
| 91917-63-4 | 人α-ANF(I-28) | Atrial natriureticpeptide-28 (human reduced) (9CI); Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-Alanine-3-deglycine-4-de-L-Proline-5-de-L-Arginine-17-L-methionine-; 13: PN: WO2004089280 SEQID: 13 unclaimed sequence; 13: PN: WO2005103087 SEQID:16 unclaimed sequence; 140: PN: WO2008058016 SEQID: 141 claimed Protein; 15:PN: US20030119021 SEQID: 14 unclaimed sequence; 15: PN: WO2008154226 SEQID: 15unclaimed Protein; 16: PN: WO0071576 SEQID: 16 unclaimed sequence; 18: PN:WO2004022003 SEQID: 4 claimed sequence; 18: PN: WO2005094420 SEQID: 4 claimedsequence; 19: PN: WO2007034498 SEQID: 18 unclaimed sequence; 1: PN: DE19942230SEQID: 6 claimed Protein; 1: PN: US20030069186 SEQID: 5 unclaimed sequence; 1:PN: US20090163421 SEQID: 1 unclaimed sequence; 1: PN: WO0185945 SEQID: 1unclaimed sequence; 2145: PN: WO03060071 SEQID: 2207 unclaimed; 21: PN:WO2004045592 SEQID: 20 unclaimed sequence; 220: PN: US20060293232 PAGE: 14unclaimed sequence; 294: PN: WO0069900 SEQID: 476 unclaimed sequence; 2: PN:GB2403533 SEQID: 2 claimed sequence; 2: PN: WO02074234 FIGURE: 3B claimedProtein; 301: PN: US20080004206 SEQID: 302 unclaimed Protein; 313: PN:WO0069900 SEQID: 495 unclaimed sequence; 38: PN: WO2005003296 SEQID: 309unclaimed sequence; 393: PN: US20090175821 SEQID: 476 claimed Protein; 3: PN:CN1278007 SEQID: 5 unclaimed sequence; 3: PN: US20080194481 SEQID: 302 claimedProtein; 439: PN: US20080312157 SEQID: 456 unclaimed sequence; 4: PN:US20080214437 SEQID: 4 claimed Protein; 4: PN: WO2009073527 SEQID: 4 claimedProtein; 4: PN: WO2009142307 SEQID: 100 claimed Protein; 5-32-Urodilatin(human); 59: PN: US6033884 SEQID: 53 unclaimed Protein; 5: PN: WO2007035600SEQID: 3 unclaimed sequence; 604: PN: WO2009058322 SEQID: 302 claimed sequence; 78: PN: WO03099862 PAGE: 45 unclaimed Protein; 7: PN: US20060183154 SEQID: 7claimed sequence; 95: PN: WO2007047504 SEQID: 179 unclaimed sequence; 99-126-natriuretic hormone peptide (human); 9: PN: US20010027181 SEQID: 1unclaimed Protein; Atriopeptin-28 (Canis familiaris reduced); |  | C127H205N45O39S3 | 详情 | 供应商 |
| 581-05-5 | α-促黑激素 | a-Melanotropin (swine); Valinamide,acetyl-L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylAlanyl-L-Arginyl-L-tryptophylglycyl-L-lysyl-L-Prolyl-,L- (7CI); a-Melanocyte-stimulating hormone(8CI); a-Melanotropin (pig); 1: PN:WO2004075830 SEQID: 1 claimed Protein; 3: PN: US20090011997 SEQID: 1 claimedProtein; 53: PN: US20030109453 SEQID: 52 claimed Protein; 97: PN: US20050282739SEQID: 71 claimed Protein; ACTH fragment analog; Ba 33761; L-Valinamide,N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylAlanyl-L-Arginyl-L-tryptophylglycyl-L-lysyl-L-Prolyl-; N-Acetyl-ACTH(1-13)-amide; N-Acetyl-ACTH-(1-13)-NH2; PN: WO9954358 SEQID: 1claimed Protein; a-MSH; a-MSH (Rana ridibunda); a-MSH (pig); a-MSH I (Oncorhynchus keta); a-MSH I (salmon); a-Melanotropin (Acipensertransmontanus); a-Melanotropin(Macaca nemestrina); a-Melanotropin (Mustela vison); a-Melanotropin (Rana ridibunda perezii); a-Melanotropin (Thunnus obesus); a-Melanotropin (camel); a-Melanotropin (horse); a-Melanotropin (human); a-Melanotropin (monkey); a-Melanotropin (ox); a-Melanotropin (sheep); a-Melanotropin (tuna); a-Melanotropin I (Oncorhynchusketa); a-N-Acetyl-ACTH-1-13-amide; a-N-acetyl-ACTH(1-13)-NH2; a1-13-Corticotropin,N-acetyl-13-L-valinamide- |  | C77H109N21O19S | 详情 | 供应商 |
| 25061-86-3 | Angiotensin II,5-L-isoleucine-8-L-Alanine- (8CI,9CI); Alanine,N-[1-[N-[N-[N-[N-(N2-a-aspartylArginyl)valyl]tyrosyl]isoleucyl]histidyl]Prolyl]- (6CI); 5-Isoleucine-8-Alanineangiotensin; 5-Isoleucine-8-Alanine-angiotensin II; 5-L-Isoleucine-8-L-Alanineangiotensin II; 8-Ala-Ang II; [8-Alanine]-5-isoleucine-angiotensin II |  | C44H67N13O12 | 详情 | 供应商 | |
| 118691-41-1 | Atrial natriureticpeptide-24 (Rana catesbeiana reduced) (9CI); Atriopeptin-21(rat reduced), 2a-endo-L-aspartic acid-6-L-serine-17-L-methionine-20-glycine-21-L-Arginine-21a-L-Arginine-21b-L-phenylAlanine-; 286: PN: WO0069900 SEQID: 468 unclaimed sequence; 289: PN: WO0069900 SEQID: 471unclaimed sequence; 386: PN: US20090175821 SEQID: 468 claimed Protein; 3: PN:US20010027181 SEQID: 5 unclaimed sequence; L-PhenylAlanine, L-seryl-L-seryl-L-a-aspartyl-L-cysteinyl-L-phenylAlanylglycyl-L-seryl-L-Arginyl-L-isoleucyl-L-a-aspartyl-L-Arginyl-L-isoleucylglycyl-L-Alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-Arginyl-L-Arginyl- |  | C103H167N37O34S3 | 详情 | 供应商 | |
| 10466-28-1 | a-Melanotropin (swine),13-L-valine-; Valine,acetyl-L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylAlanyl-L-Arginyl-L-tryptophylglycyl-L-lysyl-L-Prolyl-,L- (7CI,8CI); a-Melanotropin(pig), 13-L-valine-; 1: PN: WO0004873 SEQID: 1 claimed Protein |  | C77H108N20O20S | 详情 | 供应商 | |
| 123338-10-3 | Allatostatin 7(Diploptera punctata) (9CI); AllatostatinA 1 (Diploptera punctata); 36: PN: WO0131005 SEQID: 36 claimed Protein; AST 7; Allatostatin A 1; Allatostatin I (Diploptera punctata); Dip-allatostatin 7; Dippu-AST 7; Dipstatin 7; L-Leucinamide,L-Alanyl-L-Prolyl-L-serylglycyl-L-Alanyl-L-glutaminyl-L-Arginyl-L-leucyl-L-tyrosylglycyl-L-phenylAlanylglycyl- |  | C61H94N18O16 | 详情 | 供应商 | |
| 53697-27-1 | a1-13-Corticotropin,13-L-valinamide-; Valinamide,L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylAlanyl-L-Arginyl-L-tryptophyl-L-glycyl-L-lysyl-L-Prolyl-,L- (6CI,7CI); 1-13-ACTH amide; 174: PN: US20060293232 PAGE: 15 unclaimedsequence; ACTH1-13-NH2; Deacetyl-a-MSH; Deacetylmelanotropin; Desacetyl a-melanocyte-stimulating hormone; Desacetyl-a-MSH |  | C75H107N21O18S | 详情 | 供应商 | |
| 4474-91-3 | Angiotensin II,5-L-isoleucine-; Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-Prolyl]-3-phenyl-,L- (6CI,7CI); 10: PN: WO0212471 SEQID: 17 unclaimed sequence; 113: PN:WO2008104000 TABLE: 4 unclaimed sequence; 11: PN: US20030119021 SEQID: 10unclaimed sequence; 1272: PN: US20050069911 SEQID: 1272 unclaimed sequence; 12:PN: US20090088553 SEQID: 86 unclaimed Protein; 12: PN: WO0239997 SEQID: 17unclaimed sequence; 134: PN: WO02098448 SEQID: 144 unclaimed sequence; 134: PN:WO02098906 SEQID: 144 unclaimed sequence; 14: PN: WO2004007538 SEQID: 13claimed sequence; 154: PN: WO2009126292 TABLE: 4 unclaimed sequence; 17: PN:US6610497 SEQID: 17 unclaimed sequence; 17: PN: US6884771 SEQID: 17 unclaimedsequence; 17: PN: US6989363 SEQID: 17 unclaimed sequence; 17: PN: WO2006032674SEQID: 15 claimed sequence; 1: PN: CN101015689 SEQID: 1 claimed sequence; 1:PN: CN1706502 PAGE: 2 claimed sequence; 1: PN: US6022696 SEQID: 2 unclaimedsequence; 1: PN: WO0002905 SEQID: 1 claimed Protein; |  | C50H71N13O12 | 详情 | 供应商 | |
| 31078-12-3 | Alytesin (8CI,9CI); L-Methioninamide,5-oxo-L-Prolylglycyl-L-Arginyl-L-leucylglycyl-L-threonyl-L-glutaminyl-L-tryptophyl-L-Alanyl-L-valylglycyl-L-histidyl-L-leucyl- |  | C68H106N22O17S | 详情 | 供应商 | |
| 10587-93-6 | Angiotensin I,1-L-asparagine-5-L-valine-; Leucine,N-[N-[N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-3-phenyl-L-Alanyl]-L-histidyl]-(7CI); Leucine,N-[N-[N-[1-[N-[N-[N-[N-(N2-asparaginylArginyl)valyl]tyrosyl]valyl]histidyl]Prolyl]-3-phenylAlanyl]histidyl]-(6CI); 1-Asparagine-5-valine-angiotensin I; 2: PN: WO0069900 SEQID: 651unclaimed sequence; 5-Valine-angiotensin I aspartic-b-amide; 541: PN: US20090175821 SEQID: 651 claimedProtein; Asparaginyl1-valyl5-angiotensin |  | C61H88N18O13 | 详情 | 供应商 | |
| 154445-03-1 | Annetocin (9CI); Oxytocin,2-L-phenylAlanine-3-L-valine-4-L-Arginine-8-L-threonine-; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.; 4: PN:WO0178758 SEQID: 5 claimed Protein; Glycinamide,L-cysteinyl-L-phenylAlanyl-L-valyl-L-Arginyl-L-asparaginyl-L-cysteinyl-L-Prolyl-L-threonyl-,cyclic (1® 6)-disulfide |  | C41H64N14O11S2 | 详情 | 供应商 | |
| 53-75-8 | Angiotensin II, 1-L-b-aspartic acid-5-L-valine-(8CI,9CI); Alanine,N-[1-[N-[N-[N-[N-(N2-L-b-aspartyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-3-phenyl-(7CI); Alanine, N-[1-[N-[N-[N-[N-(N2-b-aspartylArginyl)valyl]tyrosyl]valyl]histidyl]Prolyl]-3-phenyl-(6CI); 1-L-b-Aspartic acid 5-L-valineangiotensin II; 1-b-Asp-5-Val-angiotensin II; 1-b-L-Aspartic acid-5-L-valine-angiotensin II; Ciba 33902-Ba; L-PhenylAlanine, N-[1-[N-[N-[N-[N-(N2-L-b-aspartyl-L-Arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-Prolyl]-; b-1-L-Aspartic acid-5-valineangiotensin II; b-Aspartyl1-valyl5-angiotensinII |  | C49H69N13O12 | 详情 | 供应商 | |
| 112173-60-1 | Antrin (rat) (9CI); L-PhenylAlanine,N-[N2-[N2-[N-[N2-[1-[N-[N-(1-L-Alanyl-L-Prolyl)-L-seryl]-L-a-aspartyl]-L-Prolyl]-L-Arginyl]-L-leucyl]-L-Arginyl]-L-glutaminyl]- |  | C52H83N17O15 | 详情 | 供应商 | |
| 152839-32-2 | Angiotensin I (Triakisscyllium) (9CI); AngiotensinI, 1-L-asparagine-3-L-Proline-5-L-isoleucine-9-L-glutamine-; L-Leucine,L-asparaginyl-L-Arginyl-L-Prolyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-Prolyl-L-phenylAlanyl-L-glutaminyl- |  | C61H89N17O14 | 详情 | 供应商 | |
| 18197-01-8 | Angiotensin II,5-L-isoleucine-8-L-Alanine- (8CI,9CI); Alanine,N-[1-[N-[N-[N-[N-(N2-a-aspartylArginyl)valyl]tyrosyl]isoleucyl]histidyl]Prolyl]- (6CI); 5-Isoleucine-8-Alanineangiotensin; 5-Isoleucine-8-Alanine-angiotensin II; 5-L-Isoleucine-8-L-Alanineangiotensin II; 8-Ala-Ang II; [8-Alanine]-5-isoleucine-angiotensin II |  | C44H67N13O12 | 详情 | 供应商 | |
| 58-82-2 | 舒缓激肽 | Bradykinin; Arginine,N2-[N-[1-[N-[N-[N-[1-(1-Arginyl-L-Prolyl)-L-Prolyl]glycyl]-3-phenylAlanyl]seryl]Prolyl]-3-phenylAlanyl]-(6CI); 1020: PN: EP2071336 PAGE: 73 unclaimed sequence; 1021: PN: WO2006091861SEQID: 1021 claimed Protein; 107: PN: WO2006069765 SEQID: 107 claimed Protein; 10: PN: WO2008008766 SEQID: 124 unclaimed sequence; 111: PN: WO2008058016SEQID: 112 claimed Protein; 115: PN: WO2008104000 TABLE: 4 unclaimed sequence; 11: PN: US20040209344 SEQID: 7 unclaimed Protein; 13: PN: WO0023092 SEQID: 13unclaimed Protein; 147: PN: US20030119021 SEQID: 25 unclaimed Protein; 14: PN:US20090088553 SEQID: 88 unclaimed Protein; 14: PN: US6525021 SEQID: 13unclaimed Protein; 153: PN: WO2006067198 SEQID: 165 claimed Protein; 156: PN:WO2009126292 TABLE: 4 unclaimed sequence; 15: PN: US6258776 SEQID: 24 unclaimedProtein; 15: PN: WO2007058336 SEQID: 15 claimed sequence; 165: PN:US20050175581 SEQID: 165 unclaimed Protein; 16: PN: WO2006079099 SEQID: 1unclaimed Protein; 175: PN: WO2008008805 SEQID: 178 unclaimed Protein; 187: PN:US20030176421 PAGE: 54-55 claimed Protein; 18: PN: JP2006280210 SEQID: 18unclaimed Protein; 19: PN: US20060223140 SEQID: 18 claimed Protein; 19: PN:WO2007022248 SEQID: 19 claimed Protein; 1: PN: CN101344527 PAGE: 6 claimedsequence; 1: PN: JP2005049164 SEQID: 1 claimed Protein; 1: PN: US20040198666SEQID: 1 unclaimed Protein; 1: PN: US20040220110 PAGE: 2 unclaimed Protein; 1:PN: US20070015715 SEQID: 1 unclaimed sequence; 1: PN: US7605120 SEQID: 1unclaimed sequence; 1: PN: WO02102835 SEQID: 3 unclaimed Protein; 1: PN:WO2006130718 SEQID: 1 unclaimed Protein; 1: PN: WO2006134125 SEQID: 22 claimedProtein; 227: PN: WO2009118205 PAGE: 176 unclaimed sequence; 229: PN:US20090048431 SEQID: 227 claimed sequence; 24: PN: US20080226503 TABLE: 1unclaimed sequence; 2: PN: WO2005042027 SEQID: 1 unclaimed Protein; 2: PN:WO2005057221 PAGE: 17 unclaimed Protein; 360: PN: WO2009117524 SEQID: 5unclaimed sequence; 38: PN: WO2006017688 SEQID: 38 unclaimed Protein; |  | C50H73N15O11 | 详情 | 供应商 |
| 77739-21-0 | b-Neoendorphin (human) (9CI); a-Neoendorphin (pig),10-de-L-lysine-; 10: PN: WO2007025286 SEQID: 9 unclaimed sequence; 11: PN:WO2008011381 SEQID: 67 unclaimed sequence; 120: PN: US20090048431 SEQID: 119claimed sequence; 12: PN: WO2004073646 TABLE: 3 unclaimed sequence; 141: PN:WO2008125902 SEQID: 131 unclaimed sequence; 143: PN: WO0069900 SEQID: 808unclaimed sequence; 19: PN: WO2008008805 SEQID: 19 unclaimed Protein; 22: PN:WO2007106799 SEQID: 119 unclaimed sequence; 53: PN: US20030119021 SEQID: 21unclaimed sequence; 5: PN: WO2005097158 SEQID: 5 unclaimed sequence; 657: PN:US20090175821 SEQID: 808 claimed Protein; 68: PN: US20090104234 SEQID: 68unclaimed Protein; 6: PN: WO2004075843 PAGE: 5 unclaimed sequence; 7: PN:WO2008052043 SEQID: 6 claimed Protein; 8: PN: WO2005114217 SEQID: 104 unclaimedsequence; L-Proline, 1-[N-[N2-[N2-[N-[N-[N-(N-L-tyrosylglycyl)glycyl]-L-phenylAlanyl]-L-leucyl]-L-Arginyl]-L-lysyl]-L-tyrosyl]-; b-Neoendorphin (pig); b-neo-endorphin (Bos taurus) |  | C54H77N13O12 | 详情 | 供应商 | |
